NCT07296003 Motor Development and Early Predictors of Psychomotor Outcomes in Preterm and Term Infants Assessed by MOS-R and Caregiver Questionnaire at 18 and 36 Months
| NCT ID | NCT07296003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Masaryk University |
| Condition | Neurodevelopmental Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-04-19 |
| Primary Completion | 2026-07-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-04-19 with a primary completion date of 2026-07-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines how early motor behavior in infants relates to their later psychomotor development. Researchers will observe both preterm and full-term infants during the first months of life, using video-based assessments to evaluate spontaneous movements and early postural control. These early motor patterns will be scored with the Motor Optimality Score - Revised (MOS-R). When the children reach 18 and 36 months of age, their development in areas such as motor skills, communication, sensory processing, and social behavior will be evaluated through a caregiver-completed questionnaire. The purpose of the study is to determine whether early motor quality can predict later developmental outcomes, whether preterm and full-term infants with similar motor scores develop differently, and whether early therapy may improve outcomes for infants with low MOS-R results.
Eligibility Criteria
Inclusion Criteria: * The child was born either preterm or full-term. Both groups are included in the study. * The child completed a video recording of early movements during routine check-ups in the first months of life. * The parents or legal guardians agree to participate and give informed consent. * The child will be available for follow-up at around 18-36 months of age, when parents will complete a developmental questionnaire. Exclusion Criteria: * There is no usable video recording of the child's early spontaneous movements from the neonatal or early infant period. * The child has a diagnosed medical condition that makes movement assessment impossible (for example, severe congenital anomalies or conditions preventing typical movement). * Parents do not wish to participate or withdraw their consent. * The child is not available for follow-up, meaning that the developmental questionnaire at 18-36 months cannot be completed.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07296003 clinical trial?
This trial is open to participants of all sexes, up to 3 Years, studying Neurodevelopmental Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07296003 currently recruiting?
Yes, NCT07296003 is actively recruiting participants. Contact the research team at l.teply@seznam.cz for enrollment information.
Where is the NCT07296003 trial being conducted?
This trial is being conducted at Pardubice, Czechia, Pardubice, Czechia, Pardubice, Czechia.
Who is sponsoring the NCT07296003 clinical trial?
NCT07296003 is sponsored by Masaryk University. The trial plans to enroll 60 participants.